Cover Image
Market Research Report

China Cardiac Rhythm Management Devices Market Outlook to 2025

Published by GlobalData Product code 356630
Published Content info 49 Pages
Delivery time: 1-2 business days
Price
Back to Top
China Cardiac Rhythm Management Devices Market Outlook to 2025
Published: April 2, 2018 Content info: 49 Pages
Description

GlobalData's new report, "China Cardiac Rhythm Management Devices Market Outlook to 2025", provides key market data on the China Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Cardiac Rhythm Management Devices market.
  • Global corporate-level profiles of key companies operating within the China Cardiac Rhythm Management Devices market.
  • Key players covered include Medtronic plc, Abbott Laboratories, Boston Scientific Corp. and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Table of Contents
Product Code: GDMECC3052DB

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 What Is This Report About? 5
  • 2.2 Cardiac Rhythm Management Devices Segmentation 5
  • 2.3 Definitions of Markets Covered in the Report 6

3 Cardiac Rhythm Management Devices Market, China 8

  • 3.1 Cardiac Rhythm Management Devices Market, China, Revenue ($m), 2015-2025 8
    • 3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), by Segment, 2015-2025 11
    • 3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), by Segment, 2015-2025 13
    • 3.1.3 Pacemakers Market, China, Revenue ($m), by Segment, 2015-2025 15
  • 3.2 Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2025 17
    • 3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), by Segment, 2015-2025 20
    • 3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), by Segment, 2015-2025 22
    • 3.2.3 Pacemakers Market, China, Volume (Units), by Segment, 2015-2025 24
  • 3.3 Cardiac Rhythm Management Devices Market, China, Average Price ($), 2015-2025 26
  • 3.4 Cardiac Rhythm Management Devices Market, China, Distribution Share by Revenue ($m), 2017 28
  • 3.5 Cardiac Rhythm Management Devices Market, China, Company Share by Revenue ($m), 2017 29

4 Overview of Key Companies in China, Cardiac Rhythm Management Devices Market 31

  • 4.1 Medtronic Plc 31
    • 4.1.1 Company Overview 31
  • 4.2 Abbott Laboratories 31
    • 4.2.1 Company Overview 31
  • 4.3 Boston Scientific Corp 31
    • 4.3.1 Company Overview 31
  • 4.4 Biotronik AG 31
    • 4.4.1 Company Overview 31

5 Cardiac Rhythm Management Devices Market Pipeline Products 32

6 Recent Developments 33

  • 6.1 Corporate Communications 33
    • 6.1.1 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 33
    • 6.1.2 Sep 18, 2017: Concord Medical Announces Changes to the Board 33
    • 6.1.3 Jul 24, 2017: Concord Medical Announces Changes to the Board 33
    • 6.1.4 Jul 07, 2017: MPSC New COO Glendy Wang on Board 34
  • 6.2 Financial Announcements 34
    • 6.2.1 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 34
    • 6.2.2 Aug 25, 2017: Concord Medical Reports Financial Results for the First Half of 2017 36
    • 6.2.3 Aug 15, 2017: CareRay Exhibits At FIME 2017 37
    • 6.2.4 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 38
    • 6.2.5 Mar 30, 2017: MPSC Announces 2016 Annual Results 39
  • 6.3 Other Significant Developments 40
    • 6.3.1 Jun 29, 2017: Concord Medical Announces Construction of Proton Treatment Building of Beijing Proton Medical Center 40
  • 6.4 Product News 41
    • 6.4.1 Dec 18, 2017: The CFDA Approves Impulse Dynamics' Optimizer System for Treatment of Chronic Heart Failure in China 41
    • 6.4.2 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 41
  • 6.5 Strategy And Business Planning 42
    • 6.5.1 Sep 21, 2017: Concord Medical Announces Construction of Shanghai Concord Cancer Hospital 42

7 Appendix 43

  • 7.1 Research Methodology 44
    • 7.1.1 Coverage 44
    • 7.1.2 Secondary Research 44
    • 7.1.3 Primary Research 45
    • 7.1.4 Market Modeling and Forecasting 46
    • 7.1.5 Company Share Analysis 47
    • 7.1.6 Distribution Share Analysis 48
    • 7.1.7 Benchmarking 48
  • 7.2 GlobalData Consulting 48
  • 7.3 Contact Us 49
  • 7.4 Disclaimer 49

List of Tables

1.1 List of Tables

  • Table 1: Cardiac Rhythm Management Devices Market, China, Revenue ($m), USD Constant, 2015-2020 9
  • Table 2: Cardiac Rhythm Management Devices Market, China, Revenue ($m), USD Constant, 2021-2025 10
  • Table 3: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), USD Constant, 2015-2020 12
  • Table 4: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), USD Constant, 2021-2025 12
  • Table 5: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), USD Constant, 2015-2020 14
  • Table 6: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), USD Constant, 2021-2025 14
  • Table 7: Pacemakers Market, China, Revenue ($m), USD Constant, 2015-2020 16
  • Table 8: Pacemakers Market, China, Revenue ($m), USD Constant, 2021-2025 16
  • Table 9: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2020 18
  • Table 10: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2021-2025 19
  • Table 11: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2015-2020 21
  • Table 12: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2021-2025 21
  • Table 13: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2015-2020 23
  • Table 14: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2021-2025 23
  • Table 15: Pacemakers Market, China, Volume (Units), 2015-2020 25
  • Table 16: Pacemakers Market, China, Volume (Units), 2021-2025 25
  • Table 17: Cardiac Rhythm Management Devices Market, China, Average Price ($), 2015-2020 26
  • Table 18: Cardiac Rhythm Management Devices Market, China, Average Price ($), 2021-2025 27
  • Table 19: Cardiac Rhythm Management Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2017 28
  • Table 20: Cardiac Rhythm Management Devices Market, China, Company Share by Revenue ($m), USD Constant, 2017 30
  • Table 21: Cardiac Rhythm Management Devices Market Pipeline Products 32
  • Table 22: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 46

List of Figures

1.2 List of Figures

  • Figure 1: Cardiac Rhythm Management Devices Market, China, Revenue ($m), USD Constant, 2015-2025 8
  • Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), USD Constant, 2015-2025 11
  • Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), USD Constant, 2015-2025 13
  • Figure 4: Pacemakers Market, China, Revenue ($m), USD Constant, 2015-2025 15
  • Figure 5: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2025 17
  • Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2015-2025 20
  • Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2015-2025 22
  • Figure 8: Pacemakers Market, China, Volume (Units), 2015-2025 24
  • Figure 9: Cardiac Rhythm Management Devices Market, China, Company Share (%) 2017 29
Back to Top